Abstract
Despite scientific advances, we are losing ground against Mycobacterium tuberculosis, a pathogen with which a third of us share our lives. Challenges include fundamental biologic questions; hurdles for translational medicine; and societal deficits in resources, incentives, collaboration, and leadership. Fortunately, the crisis is inspiring scientific and organizational creativity.
Publication types
-
Historical Article
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antitubercular Agents / therapeutic use
-
Biomedical Research / trends*
-
Communicable Disease Control / methods
-
History, 19th Century
-
History, 20th Century
-
History, 21st Century
-
Humans
-
Mycobacterium tuberculosis / drug effects
-
Mycobacterium tuberculosis / immunology*
-
Mycobacterium tuberculosis / physiology*
-
Tuberculosis / drug therapy
-
Tuberculosis / epidemiology*
-
Tuberculosis / history*
-
Tuberculosis / prevention & control
-
United States